| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99284 |
Emergency department visit for the evaluation and management, high severity |
37,243 |
34,589 |
$7.88M |
| 99285 |
Emergency department visit for the evaluation and management, high severity with immediate threat to life |
19,761 |
18,756 |
$5.31M |
| 99283 |
Emergency department visit for the evaluation and management, moderate severity |
26,936 |
25,203 |
$4.13M |
| 74177 |
Computed tomography, abdomen and pelvis; with contrast material |
6,174 |
5,991 |
$2.09M |
| 76805 |
Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation |
14,820 |
14,290 |
$1.83M |
| 76819 |
Fetal biophysical profile; without non-stress testing |
15,708 |
11,198 |
$1.76M |
| G0463 |
Hospital outpatient clinic visit for assessment and management of a patient |
20,528 |
17,809 |
$1.59M |
| 76820 |
|
15,995 |
11,169 |
$1.24M |
| 59025 |
Fetal non-stress test |
9,317 |
7,339 |
$1.18M |
| 76825 |
|
3,248 |
3,140 |
$1.12M |
| 97110 |
Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion |
20,431 |
8,440 |
$1.01M |
| 43239 |
Esophagogastroduodenoscopy, flexible, transoral; with biopsy, single or multiple |
3,261 |
3,197 |
$996K |
| 93005 |
Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report |
16,948 |
15,440 |
$927K |
| 58661 |
|
425 |
377 |
$892K |
| 80053 |
Comprehensive metabolic panel |
35,952 |
32,839 |
$892K |
| 76811 |
Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation, detailed |
3,228 |
3,181 |
$853K |
| 70450 |
Computed tomography, head or brain; without contrast material |
4,344 |
4,168 |
$798K |
| 93306 |
Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete |
2,017 |
1,986 |
$716K |
| 76817 |
Ultrasound, pregnant uterus, real time with image documentation, transvaginal |
7,986 |
7,462 |
$710K |
| 96374 |
Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance |
19,481 |
18,087 |
$688K |
| 87636 |
Infectious agent detection by nucleic acid; SARS-CoV-2 and influenza virus types A and B |
8,778 |
8,509 |
$679K |
| 96375 |
Therapeutic injection; each additional sequential IV push |
12,858 |
11,444 |
$629K |
| 45380 |
Colonoscopy, flexible; with biopsy, single or multiple |
1,976 |
1,950 |
$616K |
| 93976 |
|
5,190 |
4,941 |
$598K |
| 85025 |
Blood count; complete (CBC), automated, and automated differential WBC count |
45,392 |
40,465 |
$579K |
| 97140 |
Manual therapy techniques, each 15 minutes (e.g., mobilization/manipulation, manual lymphatic drainage) |
14,045 |
6,069 |
$577K |
| 96361 |
Intravenous infusion, hydration; each additional hour |
7,528 |
6,642 |
$576K |
| 77067 |
Screening mammography, bilateral, including computer-aided detection |
4,873 |
4,851 |
$571K |
| 76815 |
Ultrasound, pregnant uterus, real time with image documentation, limited |
6,191 |
3,854 |
$564K |
| 74176 |
Computed tomography, abdomen and pelvis; without contrast material |
2,196 |
2,141 |
$562K |
| 76856 |
Ultrasound, pelvic (nonobstetric), real time with image documentation; complete |
5,200 |
5,021 |
$552K |
| G0378 |
Hospital observation service, per hour |
1,143 |
1,067 |
$511K |
| 93325 |
|
3,620 |
3,507 |
$467K |
| 76830 |
Ultrasound, transvaginal |
4,762 |
4,598 |
$465K |
| 76801 |
|
4,466 |
4,168 |
$465K |
| 80307 |
Drug test(s), presumptive, any number of drug classes; immunoassay |
3,991 |
3,754 |
$416K |
| 64493 |
|
925 |
626 |
$324K |
| G0480 |
Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed |
4,070 |
3,681 |
$316K |
| 99282 |
Emergency department visit for the evaluation and management, low to moderate severity |
3,449 |
3,343 |
$292K |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
8,874 |
8,185 |
$292K |
| 76705 |
Ultrasound, abdominal, real time with image documentation; limited |
2,916 |
2,833 |
$280K |
| 77063 |
Screening digital breast tomosynthesis, bilateral |
4,788 |
4,766 |
$268K |
| 45385 |
Colonoscopy, flexible; with removal of tumor(s), polyp(s), or other lesion(s) |
915 |
894 |
$262K |
| 71045 |
Radiologic examination, chest; single view |
6,457 |
6,135 |
$258K |
| 84703 |
|
14,843 |
14,056 |
$251K |
| 71046 |
Radiologic examination, chest; 2 views |
4,924 |
4,755 |
$244K |
| 96365 |
Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour |
2,310 |
2,217 |
$242K |
| U0003 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r |
3,014 |
2,905 |
$238K |
| 77066 |
Tomosynthesis, mammo |
1,708 |
1,698 |
$226K |
| 76642 |
|
2,741 |
2,489 |
$223K |
| 36415 |
Collection of venous blood by venipuncture |
52,292 |
45,820 |
$219K |
| 87086 |
Culture, bacterial; quantitative colony count, urine |
12,658 |
11,917 |
$217K |
| 87631 |
|
2,268 |
2,192 |
$208K |
| 58571 |
|
85 |
82 |
$199K |
| G0279 |
Diagnostic digital breast tomosynthesis, unilateral or bilateral (list separately in addition to 77065 or 77066) |
2,668 |
2,647 |
$192K |
| 97162 |
|
3,172 |
3,148 |
$192K |
| 83690 |
|
12,396 |
11,544 |
$191K |
| 94664 |
|
1,992 |
1,870 |
$183K |
| 64494 |
|
914 |
614 |
$180K |
| C9290 |
Injection, bupivacaine liposome, 1 mg |
624 |
610 |
$177K |
| 96360 |
Intravenous infusion, hydration; initial, 31 minutes to 1 hour |
2,060 |
2,005 |
$174K |
| 64635 |
|
436 |
354 |
$174K |
| 76813 |
|
2,336 |
2,293 |
$167K |
| 76700 |
Ultrasound, abdominal, real time with image documentation; complete |
1,613 |
1,597 |
$166K |
| 64636 |
|
423 |
351 |
$155K |
| 81001 |
|
20,113 |
18,835 |
$151K |
| 71275 |
Computed tomographic angiography, chest, with contrast material |
523 |
503 |
$145K |
| 73030 |
|
1,963 |
1,817 |
$144K |
| 84702 |
|
5,176 |
4,620 |
$131K |
| 72125 |
Computed tomography, cervical spine; without contrast material |
674 |
648 |
$129K |
| 84484 |
|
7,497 |
6,339 |
$127K |
| 76641 |
|
1,594 |
1,006 |
$127K |
| 73130 |
|
2,196 |
1,971 |
$125K |
| 73564 |
|
1,290 |
1,099 |
$119K |
| 76536 |
|
1,161 |
1,154 |
$118K |
| 76826 |
|
403 |
393 |
$117K |
| G0283 |
Electrical stimulation (unattended), to one or more areas for indication(s) other than wound care, as part of a therapy plan of care |
5,625 |
2,679 |
$113K |
| 91200 |
|
799 |
792 |
$111K |
| 77065 |
Tomosynthesis, mammo |
996 |
938 |
$105K |
| 73562 |
|
1,434 |
1,376 |
$103K |
| 99281 |
Emergency department visit for the evaluation and management, self-limited or minor |
2,028 |
1,921 |
$103K |
| 87040 |
|
3,334 |
1,896 |
$100K |
| 73610 |
|
1,314 |
1,269 |
$99K |
| 93971 |
|
1,185 |
1,144 |
$99K |
| 47563 |
|
42 |
42 |
$96K |
| Q9967 |
Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml |
8,175 |
7,867 |
$93K |
| 87651 |
Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe |
3,684 |
3,617 |
$89K |
| 87491 |
Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe |
2,616 |
2,526 |
$89K |
| 96366 |
Intravenous infusion, for therapy, prophylaxis, or diagnosis; each additional hour |
728 |
562 |
$89K |
| 87591 |
Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe |
2,615 |
2,525 |
$89K |
| C1713 |
Anchor/screw for opposing bone-to-bone or soft tissue-to-bone (implantable) |
282 |
270 |
$88K |
| 80048 |
Basic metabolic panel (calcium, ionized) |
4,556 |
3,922 |
$87K |
| 96376 |
|
2,935 |
2,344 |
$85K |
| 73630 |
|
1,329 |
1,272 |
$82K |
| 83605 |
|
3,184 |
2,632 |
$77K |
| J7120 |
Ringers lactate infusion, up to 1000 cc |
12,726 |
11,890 |
$76K |
| 73110 |
|
1,326 |
1,184 |
$76K |
| 64495 |
|
369 |
299 |
$71K |
| 80076 |
|
2,752 |
2,459 |
$63K |
| 97035 |
|
3,026 |
1,427 |
$58K |
| 97530 |
Therapeutic activities, direct patient contact, each 15 minutes |
1,168 |
734 |
$53K |
| 82962 |
|
6,040 |
4,128 |
$51K |
| 83735 |
|
4,433 |
3,638 |
$51K |
| 86850 |
|
4,257 |
4,081 |
$50K |
| J7030 |
Infusion, normal saline solution , 1000 cc |
8,439 |
7,563 |
$45K |
| 82565 |
|
3,740 |
3,359 |
$42K |
| 94760 |
|
2,404 |
2,088 |
$41K |
| 19083 |
|
76 |
74 |
$39K |
| 93017 |
|
221 |
215 |
$39K |
| 87186 |
|
2,300 |
2,176 |
$39K |
| 70486 |
|
197 |
191 |
$38K |
| 72100 |
|
520 |
511 |
$38K |
| 76775 |
|
423 |
417 |
$37K |
| 83880 |
|
1,214 |
1,143 |
$37K |
| 87077 |
|
2,899 |
2,735 |
$37K |
| 86900 |
|
6,024 |
5,687 |
$37K |
| G0121 |
Colorectal cancer screening; colonoscopy on individual not meeting criteria for high risk |
112 |
108 |
$36K |
| 84443 |
Thyroid stimulating hormone (TSH) |
1,640 |
1,596 |
$36K |
| J2704 |
Injection, propofol, 10 mg |
7,227 |
7,066 |
$36K |
| 84112 |
|
1,112 |
1,022 |
$36K |
| 85610 |
|
3,972 |
3,747 |
$36K |
| 72148 |
Magnetic resonance imaging, lumbar spine; without contrast material |
117 |
115 |
$36K |
| 81003 |
|
9,407 |
8,993 |
$35K |
| 74018 |
|
640 |
618 |
$33K |
| 87210 |
|
2,842 |
2,719 |
$32K |
| 81002 |
|
9,494 |
7,599 |
$31K |
| 76770 |
|
316 |
316 |
$31K |
| 94640 |
Pressurized or nonpressurized inhalation treatment for acute airway obstruction |
220 |
166 |
$30K |
| 86901 |
|
6,024 |
5,687 |
$30K |
| 45378 |
Colonoscopy, flexible; diagnostic, including collection of specimen(s) |
81 |
78 |
$29K |
| 64490 |
|
106 |
77 |
$28K |
| 81025 |
|
3,648 |
3,602 |
$27K |
| 82330 |
|
1,637 |
1,525 |
$26K |
| 99291 |
Critical care, evaluation and management of the critically ill patient, first 30-74 minutes |
64 |
62 |
$26K |
| 88305 |
Level IV - Surgical pathology, gross and microscopic examination |
471 |
370 |
$25K |
| 90471 |
Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine |
1,151 |
1,117 |
$24K |
| 85379 |
|
1,356 |
1,316 |
$23K |
| 97112 |
Therapeutic procedure, each 15 minutes; neuromuscular reeducation of movement, balance, coordination |
534 |
347 |
$23K |
| 83615 |
|
1,833 |
1,515 |
$23K |
| 73502 |
|
443 |
422 |
$23K |
| 80051 |
|
1,493 |
1,406 |
$22K |
| 80305 |
|
2,003 |
1,967 |
$22K |
| 84550 |
|
1,801 |
1,519 |
$21K |
| 88307 |
|
87 |
84 |
$21K |
| 77080 |
|
268 |
268 |
$21K |
| 87634 |
|
456 |
453 |
$20K |
| 85730 |
|
2,059 |
1,985 |
$20K |
| 82570 |
|
1,661 |
1,382 |
$19K |
| 84156 |
|
1,661 |
1,346 |
$19K |
| C8908 |
Magnetic resonance imaging without contrast followed by with contrast, breast; bilateral |
38 |
38 |
$19K |
| 64491 |
|
100 |
76 |
$18K |
| 82947 |
|
1,537 |
1,449 |
$18K |
| 84520 |
|
1,567 |
1,480 |
$17K |
| 73080 |
|
310 |
295 |
$16K |
| 97535 |
Self-care/home management training, each 15 minutes |
461 |
292 |
$16K |
| 97161 |
|
402 |
396 |
$16K |
| G0500 |
Moderate sedation services provided by the same physician or other qualified health care professional performing a gastrointestinal endoscopic service that sedation supports, requiring the presence of an independent trained observer to assist in the monitoring of the patient's level of consciousness and physiological status; initial 15 minutes of intra-service time; patient age 5 years or older (additional time may be reported with 99153, as appropriate) |
954 |
933 |
$14K |
| 71250 |
|
77 |
77 |
$13K |
| 97018 |
|
1,233 |
553 |
$12K |
| 29125 |
|
106 |
104 |
$12K |
| 73221 |
|
33 |
31 |
$12K |
| A9577 |
Injection, gadobenate dimeglumine (multihance), per ml |
469 |
451 |
$12K |
| 97165 |
|
242 |
241 |
$12K |
| 12001 |
|
129 |
125 |
$12K |
| J2405 |
Injection, ondansetron hydrochloride, per 1 mg |
9,059 |
7,712 |
$12K |
| J7040 |
Infusion, normal saline solution, sterile (500 ml = 1 unit) |
2,600 |
2,497 |
$11K |
| 90715 |
|
1,081 |
1,053 |
$11K |
| 72131 |
|
66 |
66 |
$11K |
| 85027 |
|
1,463 |
1,283 |
$11K |
| 94761 |
|
451 |
340 |
$10K |
| 85014 |
|
1,965 |
1,819 |
$9K |
| J1885 |
Injection, ketorolac tromethamine, per 15 mg |
6,251 |
5,836 |
$9K |
| 86780 |
|
499 |
462 |
$9K |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
511 |
494 |
$8K |
| A4648 |
Tissue marker, implantable, any type, each |
205 |
199 |
$8K |
| 72110 |
|
79 |
79 |
$8K |
| U0002 |
2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc |
215 |
208 |
$8K |
| 88342 |
|
130 |
124 |
$8K |
| 87650 |
|
335 |
324 |
$8K |
| J3010 |
Injection, fentanyl citrate, 0.1 mg |
4,965 |
4,128 |
$8K |
| 64492 |
|
50 |
40 |
$7K |
| 78452 |
Myocardial perfusion imaging, tomographic (SPECT); multiple studies at rest and/or stress |
14 |
14 |
$7K |
| J1100 |
Injection, dexamethasone sodium phosphate, 1 mg |
4,463 |
4,336 |
$7K |
| J0561 |
Injection, penicillin g benzathine, 100,000 units |
116 |
110 |
$7K |
| J0131 |
Injection, acetaminophen, not otherwise specified,10 mg |
692 |
677 |
$7K |
| 70553 |
Magnetic resonance imaging, brain; without contrast material, followed by contrast material and further sequences |
14 |
14 |
$6K |
| 10060 |
|
70 |
67 |
$6K |
| J7050 |
Infusion, normal saline solution, 250 cc |
1,327 |
1,177 |
$6K |
| 74022 |
|
82 |
80 |
$6K |
| 86703 |
|
358 |
339 |
$6K |
| 93970 |
|
41 |
40 |
$6K |
| C8929 |
Transthoracic echocardiography with contrast, or without contrast followed by with contrast, real-time with image documentation (2d), includes m-mode recording, when performed, complete, with spectral doppler echocardiography, and with color flow doppler echocardiography |
15 |
15 |
$5K |
| 76870 |
|
50 |
50 |
$5K |
| 73721 |
Magnetic resonance imaging, any joint of lower extremity; without contrast material |
14 |
13 |
$5K |
| 87632 |
|
20 |
20 |
$5K |
| 86762 |
|
277 |
258 |
$5K |
| 80143 |
|
435 |
418 |
$5K |
| 82150 |
|
401 |
381 |
$5K |
| 80179 |
|
431 |
413 |
$5K |
| 71260 |
Computed tomography, thorax, diagnostic; with contrast material |
24 |
24 |
$5K |
| 87081 |
|
259 |
254 |
$4K |
| 87340 |
|
286 |
269 |
$4K |
| 43235 |
|
15 |
15 |
$4K |
| 72040 |
|
57 |
53 |
$4K |
| 83036 |
Hemoglobin; glycosylated (A1C) |
361 |
344 |
$4K |
| 87339 |
|
296 |
290 |
$4K |
| 84439 |
|
233 |
228 |
$4K |
| J2250 |
Injection, midazolam hydrochloride, per 1 mg |
2,570 |
2,495 |
$4K |
| 86803 |
|
210 |
199 |
$3K |
| J0690 |
Injection, cefazolin sodium, 500 mg |
2,789 |
2,459 |
$3K |
| C1781 |
Mesh (implantable) |
44 |
41 |
$3K |
| 76821 |
|
38 |
13 |
$3K |
| 87522 |
Neg quan hep c or qual rna |
54 |
54 |
$3K |
| J2795 |
Injection, ropivacaine hydrochloride, 1 mg |
77 |
70 |
$3K |
| 99153 |
Mod sedat endo service >5yrs |
243 |
236 |
$3K |
| J3490 |
Unclassified drugs |
171 |
165 |
$3K |
| 85007 |
|
536 |
504 |
$3K |
| J1170 |
Injection, hydromorphone, up to 4 mg |
1,652 |
1,413 |
$3K |
| 64633 |
|
14 |
12 |
$3K |
| 72050 |
|
28 |
28 |
$3K |
| J0330 |
Injection, succinylcholine chloride, up to 20 mg |
777 |
770 |
$2K |
| 73140 |
|
40 |
40 |
$2K |
| J0696 |
Injection, ceftriaxone sodium, per 250 mg |
1,751 |
1,616 |
$2K |
| A9579 |
Injection, gadolinium-based magnetic resonance contrast agent, not otherwise specified (nos), per ml |
65 |
64 |
$2K |
| A4615 |
Cannula, nasal |
6,165 |
6,055 |
$2K |
| 80061 |
Lipid panel |
106 |
105 |
$2K |
| J1596 |
Injection, glycopyrrolate, 0.1 mg |
373 |
362 |
$2K |
| 71101 |
|
24 |
24 |
$2K |
| 82731 |
|
25 |
24 |
$2K |
| J1200 |
Injection, diphenhydramine hcl, up to 50 mg |
1,202 |
1,142 |
$2K |
| 82550 |
|
178 |
166 |
$2K |
| J2272 |
Injection, morphine sulfate (fresenius kabi), not therapeutically equivalent to j2270, up to 10 mg |
1,164 |
1,016 |
$2K |
| J0780 |
Injection, prochlorperazine, up to 10 mg |
531 |
504 |
$2K |
| 86140 |
|
214 |
209 |
$2K |
| 82553 |
|
109 |
100 |
$2K |
| 73090 |
|
26 |
26 |
$1K |
| C9399 |
Unclassified drugs or biologicals |
55 |
54 |
$1K |
| 74220 |
|
18 |
18 |
$1K |
| 87070 |
|
121 |
104 |
$1K |
| C1769 |
Guide wire |
85 |
83 |
$1K |
| J2765 |
Injection, metoclopramide hcl, up to 10 mg |
1,016 |
961 |
$1K |
| 80074 |
|
24 |
24 |
$1K |
| 84100 |
|
152 |
113 |
$1K |
| Q9950 |
Injection, sulfur hexafluoride lipid microspheres, per ml |
15 |
15 |
$1K |
| J2270 |
Injection, morphine sulfate, up to 10 mg |
621 |
533 |
$1K |
| 29515 |
|
19 |
18 |
$1K |
| 72070 |
|
12 |
12 |
$1K |
| J2060 |
Injection, lorazepam, 2 mg |
808 |
724 |
$1K |
| 73590 |
|
26 |
25 |
$999.73 |
| J3475 |
Injection, magnesium sulfate, per 500 mg |
196 |
187 |
$930.83 |
| A9270 |
Non-covered item or service |
1,718 |
807 |
$906.27 |
| 87205 |
|
135 |
118 |
$771.37 |
| J0665 |
Injection, bupivicaine, not otherwise specified, 0.5 mg |
703 |
692 |
$769.10 |
| C2617 |
Stent, non-coronary, temporary, without delivery system |
28 |
27 |
$756.14 |
| 97163 |
|
12 |
12 |
$737.95 |
| 85652 |
|
125 |
122 |
$700.15 |
| J0137 |
Injection, acetaminophen (hikma), not therapeutically equivalent to j0131, 10 mg |
258 |
254 |
$686.24 |
| 76377 |
|
12 |
12 |
$673.45 |
| 99156 |
|
24 |
24 |
$591.92 |
| A9578 |
Injection, gadobenate dimeglumine (multihance multipack), per ml |
17 |
15 |
$583.22 |
| J0500 |
Injection, dicyclomine hcl, up to 20 mg |
64 |
61 |
$574.64 |
| A9502 |
Technetium tc-99m tetrofosmin, diagnostic, per study dose |
14 |
14 |
$567.84 |
| J1790 |
Injection, droperidol, up to 5 mg |
452 |
419 |
$552.16 |
| J2003 |
Injection, lidocaine hydrochloride, 1 mg |
288 |
267 |
$466.18 |
| J2930 |
Injection, methylprednisolone sodium succinate, up to 125 mg |
150 |
142 |
$456.11 |
| 82272 |
|
108 |
102 |
$451.74 |
| 87075 |
|
42 |
37 |
$435.06 |
| J2371 |
Injection, phenylephrine hydrochloride, 20 micrograms |
259 |
250 |
$337.89 |
| 97116 |
|
23 |
12 |
$325.39 |
| 82803 |
|
13 |
12 |
$318.86 |
| J1650 |
Injection, enoxaparin sodium, 10 mg |
181 |
142 |
$309.12 |
| 84481 |
|
14 |
14 |
$295.20 |
| 82728 |
|
13 |
13 |
$228.53 |
| S0119 |
Ondansetron, oral, 4 mg (for circumstances falling under the medicare statute, use hcpcs q code) |
490 |
474 |
$227.16 |
| J1644 |
Injection, heparin sodium, per 1000 units |
127 |
100 |
$221.69 |
| J7512 |
Prednisone, immediate release or delayed release, oral, 1 mg |
314 |
294 |
$201.05 |
| 36416 |
|
104 |
92 |
$196.61 |
| J0687 |
Injection, cefazolin sodium (wg critical care), not therapeutically equivalent to j0690, 500 mg |
214 |
186 |
$193.55 |
| 82760 |
|
13 |
12 |
$177.76 |
| Q0162 |
Ondansetron 1 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at the time of chemotherapy treatment, not to exceed a 48 hour dosage regimen |
204 |
191 |
$167.78 |
| 84450 |
|
21 |
17 |
$164.35 |
| J8540 |
Dexamethasone, oral, 0.25 mg |
242 |
236 |
$161.21 |
| 85018 |
|
39 |
32 |
$157.51 |
| J2360 |
Injection, orphenadrine citrate, up to 60 mg |
49 |
49 |
$157.32 |
| 82977 |
|
14 |
12 |
$153.46 |
| 84460 |
|
21 |
17 |
$146.14 |
| 83550 |
|
12 |
12 |
$140.88 |
| A6222 |
Gauze, impregnated with other than water, normal saline, or hydrogel, sterile, pad size 16 sq. in. or less, without adhesive border, each dressing |
71 |
67 |
$130.24 |
| 83540 |
|
12 |
12 |
$112.48 |
| 99157 |
|
13 |
13 |
$81.74 |
| J2175 |
Injection, meperidine hydrochloride, per 100 mg |
79 |
74 |
$81.14 |
| J1171 |
Injection, hydromorphone, 0.1 mg |
51 |
45 |
$79.36 |
| J0134 |
Injection, acetaminophen (fresenius kabi), not therapeutically equivalent to j0131, 10 mg |
29 |
29 |
$79.23 |
| J3480 |
Injection, potassium chloride, per 2 meq |
16 |
12 |
$78.74 |
| C9113 |
Injection, pantoprazole sodium, per vial |
40 |
31 |
$60.94 |
| J1630 |
Injection, haloperidol, up to 5 mg |
30 |
29 |
$45.57 |
| G8978 |
Mobility: walking & moving around functional limitation, current status, at therapy episode outset and at reporting intervals |
219 |
210 |
$35.87 |
| J0171 |
Injection, adrenalin, epinephrine, 0.1 mg |
17 |
12 |
$32.59 |
| J2543 |
Injection, piperacillin sodium/tazobactam sodium, 1 gram/0.125 grams (1.125 grams) |
14 |
12 |
$25.08 |
| J2370 |
Injection, phenylephrine hcl, up to 1 ml |
13 |
13 |
$14.50 |
| J2550 |
Injection, promethazine hcl, up to 50 mg |
14 |
13 |
$6.90 |
| G8979 |
Mobility: walking & moving around functional limitation, projected goal status, at therapy episode outset, at reporting intervals, and at discharge or to end reporting |
282 |
262 |
$0.00 |
| G1004 |
Clinical decision support mechanism national decision support company, as defined by the medicare appropriate use criteria program |
262 |
210 |
$0.00 |